185 related articles for article (PubMed ID: 27528750)
1. The role of Trim25 in development, disease and RNA metabolism.
Heikel G; Choudhury NR; Michlewski G
Biochem Soc Trans; 2016 Aug; 44(4):1045-50. PubMed ID: 27528750
[TBL] [Abstract][Full Text] [Related]
2. RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination.
Choudhury NR; Heikel G; Trubitsyna M; Kubik P; Nowak JS; Webb S; Granneman S; Spanos C; Rappsilber J; Castello A; Michlewski G
BMC Biol; 2017 Nov; 15(1):105. PubMed ID: 29117863
[TBL] [Abstract][Full Text] [Related]
3. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
Zang HL; Ren SN; Cao H; Tian XF
IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
[TBL] [Abstract][Full Text] [Related]
4. TRIM25 and its emerging RNA-binding roles in antiviral defense.
Choudhury NR; Heikel G; Michlewski G
Wiley Interdiscip Rev RNA; 2020 Jul; 11(4):e1588. PubMed ID: 31990130
[TBL] [Abstract][Full Text] [Related]
5. RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation.
Wu SF; Xia L; Shi XD; Dai YJ; Zhang WN; Zhao JM; Zhang W; Weng XQ; Lu J; Le HY; Tao SC; Zhu J; Chen Z; Wang YY; Chen S
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14395-14404. PubMed ID: 32513696
[TBL] [Abstract][Full Text] [Related]
6. The E3 ubiquitin ligase TRIM25 regulates adipocyte differentiation via proteasome-mediated degradation of PPARγ.
Lee JM; Choi SS; Lee YH; Khim KW; Yoon S; Kim BG; Nam D; Suh PG; Myung K; Choi JH
Exp Mol Med; 2018 Oct; 50(10):1-11. PubMed ID: 30323259
[TBL] [Abstract][Full Text] [Related]
7. Trim25 Is an RNA-Specific Activator of Lin28a/TuT4-Mediated Uridylation.
Choudhury NR; Nowak JS; Zuo J; Rappsilber J; Spoel SH; Michlewski G
Cell Rep; 2014 Nov; 9(4):1265-72. PubMed ID: 25457611
[TBL] [Abstract][Full Text] [Related]
8. Nuclear TRIM25 Specifically Targets Influenza Virus Ribonucleoproteins to Block the Onset of RNA Chain Elongation.
Meyerson NR; Zhou L; Guo YR; Zhao C; Tao YJ; Krug RM; Sawyer SL
Cell Host Microbe; 2017 Nov; 22(5):627-638.e7. PubMed ID: 29107643
[TBL] [Abstract][Full Text] [Related]
9. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.
Wang S; Kollipara RK; Humphries CG; Ma SH; Hutchinson R; Li R; Siddiqui J; Tomlins SA; Raj GV; Kittler R
Oncotarget; 2016 Oct; 7(40):64921-64931. PubMed ID: 27626314
[TBL] [Abstract][Full Text] [Related]
11. All Paths Lead to TRIM25.
Zhou H; Costello JC
Trends Cancer; 2017 Oct; 3(10):673-675. PubMed ID: 28958384
[TBL] [Abstract][Full Text] [Related]
12. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein.
Rajsbaum R; Albrecht RA; Wang MK; Maharaj NP; Versteeg GA; Nistal-Villán E; García-Sastre A; Gack MU
PLoS Pathog; 2012; 8(11):e1003059. PubMed ID: 23209422
[TBL] [Abstract][Full Text] [Related]
13. TRIM25 Is Required for the Antiviral Activity of Zinc Finger Antiviral Protein.
Zheng X; Wang X; Tu F; Wang Q; Fan Z; Gao G
J Virol; 2017 May; 91(9):. PubMed ID: 28202764
[TBL] [Abstract][Full Text] [Related]
14. TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.
Takayama KI; Suzuki T; Tanaka T; Fujimura T; Takahashi S; Urano T; Ikeda K; Inoue S
Oncogene; 2018 Apr; 37(16):2165-2180. PubMed ID: 29379164
[TBL] [Abstract][Full Text] [Related]
15. TRIM25 Binds RNA to Modulate Cellular Anti-viral Defense.
Sanchez JG; Sparrer KMJ; Chiang C; Reis RA; Chiang JJ; Zurenski MA; Wan Y; Gack MU; Pornillos O
J Mol Biol; 2018 Dec; 430(24):5280-5293. PubMed ID: 30342007
[TBL] [Abstract][Full Text] [Related]
16. TRIM25 inhibits influenza A virus infection, destabilizes viral mRNA, but is redundant for activating the RIG-I pathway.
Choudhury NR; Trus I; Heikel G; Wolczyk M; Szymanski J; Bolembach A; Dos Santos Pinto RM; Smith N; Trubitsyna M; Gaunt E; Digard P; Michlewski G
Nucleic Acids Res; 2022 Jul; 50(12):7097-7114. PubMed ID: 35736141
[TBL] [Abstract][Full Text] [Related]
17. RIPLET, and not TRIM25, is required for endogenous RIG-I-dependent antiviral responses.
Hayman TJ; Hsu AC; Kolesnik TB; Dagley LF; Willemsen J; Tate MD; Baker PJ; Kershaw NJ; Kedzierski L; Webb AI; Wark PA; Kedzierska K; Masters SL; Belz GT; Binder M; Hansbro PM; Nicola NA; Nicholson SE
Immunol Cell Biol; 2019 Oct; 97(9):840-852. PubMed ID: 31335993
[TBL] [Abstract][Full Text] [Related]
18. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274
[TBL] [Abstract][Full Text] [Related]
19. TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP).
Li MM; Lau Z; Cheung P; Aguilar EG; Schneider WM; Bozzacco L; Molina H; Buehler E; Takaoka A; Rice CM; Felsenfeld DP; MacDonald MR
PLoS Pathog; 2017 Jan; 13(1):e1006145. PubMed ID: 28060952
[TBL] [Abstract][Full Text] [Related]
20. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses.
Oshiumi H; Miyashita M; Matsumoto M; Seya T
PLoS Pathog; 2013; 9(8):e1003533. PubMed ID: 23950712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
